Jeremy Castle - 03 Dec 2024 Form 4 Insider Report for Oncology Institute, Inc. (TOI)

Role
Chief Operating Officer
Signature
/s/ Mark Hueppelheuser, Attorney-in-fact for Jeremy Castle
Issuer symbol
TOI
Transactions as of
03 Dec 2024
Net transactions value
-$181
Form type
4
Filing time
05 Dec 2024, 16:02:18 UTC
Previous filing
23 May 2024
Next filing
28 Mar 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TOI Common stock Disposed to Issuer $181 -1,130 -1.4% $0.1600 81,330 03 Dec 2024 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The sales reported in this Form 4 were effected to cover tax withholding obligations in connection with the vesting of restricted stock units (RSUs) pursuant to a sell-to-cover provision included in the RSU Agreement.
F2 Price is the volume weighted average selling price of all sales by the Reporting Person on December 3, 2024 within a one-dollar range. Actual prices ranged from $0.156 to $0.160. The Reporting Person hereby undertakes to provide upon request of the Commission staff full information regarding the number of shares sold at each separate price.